BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18164079)

  • 21. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates.
    Limbach K; Aguiar J; Gowda K; Patterson N; Abot E; Sedegah M; Sacci J; Richie T
    Malar J; 2011 Mar; 10():65. PubMed ID: 21410955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
    Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.
    Bruder JT; Stefaniak ME; Patterson NB; Chen P; Konovalova S; Limbach K; Campo JJ; Ettyreddy D; Li S; Dubovsky F; Richie TL; King CR; Long CA; Doolan DL
    Vaccine; 2010 Apr; 28(18):3201-10. PubMed ID: 20188680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration.
    Cherif MS; Shuaibu MN; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Tsuboi T; Sasaki H; Hirayama K
    Vaccine; 2011 Nov; 29(48):9038-50. PubMed ID: 21939717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines.
    Sedegah M; Rogers WO; Belmonte A; Belmonte M; Banania G; Patterson N; Ferrari M; Kaslow DC; Carucci DJ; Richie TL; Doolan DL
    Vaccine; 2006 Mar; 24(11):1921-7. PubMed ID: 16298024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection.
    Logan GJ; Wang L; Zheng M; Cunningham SC; Coppel RL; Alexander IE
    Vaccine; 2007 Jan; 25(6):1014-22. PubMed ID: 17081661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria.
    Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF
    mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens.
    Stone BC; Kas A; Billman ZP; Fuller DH; Fuller JT; Shendure J; Murphy SC
    PLoS One; 2016; 11(4):e0153449. PubMed ID: 27070430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
    Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL
    J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid.
    Sakai T; Horii T; Hisaeda H; Zhang M; Ishii K; Nakano Y; Maekawa Y; Izumi K; Nitta Y; Miyazaki J; Himeno K
    Parasitol Int; 1999 Mar; 48(1):27-33. PubMed ID: 11269323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.
    Ma C; Wang L; Webster DE; Campbell AE; Coppel RL
    Appl Microbiol Biotechnol; 2012 Apr; 94(1):151-61. PubMed ID: 22170105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities.
    Luo K; Zhang H; Zavala F; Biragyn A; Espinosa DA; Markham RB
    PLoS One; 2014; 9(3):e90413. PubMed ID: 24599116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.
    Brahimi K; Badell E; Sauzet JP; BenMohamed L; Daubersies P; Guérin-Marchand C; Snounou G; Druilhe P
    Infect Immun; 2001 Jun; 69(6):3845-52. PubMed ID: 11349050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The humoral immune responses elicited in mice by inoculations with a recombinant protein or DNA based on the circumsporozoite-protein gene of Plasmodium falciparum.
    Fang Z; Liu YW; Shi YK; Yu XB; Huang WQ; Ji X
    Ann Trop Med Parasitol; 2002 Jul; 96(5):463-8. PubMed ID: 12194706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses.
    Baruch DI; Gamain B; Miller LH
    Infect Immun; 2003 Aug; 71(8):4536-43. PubMed ID: 12874333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.